Peter Rossing
Clinical Professor
Department of Clinical Medicine
Niels Steensens Vej 2-4, 2820 Gentofte
Member of:
Internal Medicine: Endocrinology
- 2022
- Published
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
Rossing, Peter, Burgess, E., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Gillard, P., Macisaac, R. J., Wainstein, J., Joseph, A., Brinker, M., Roessig, L., Scott, C., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Diabetes Care. 45, 4, p. 888-897 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., McGill, J. B., Rosas, S. E., Joseph, A., Gebel, M., Roberts, L., Scheerer, M. F., Bakris, G. L. & Agarwal, R., 2022, In: Diabetes Care. 45, 12, p. 2991-2998 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy
FIDELIO-DKD Investigators, F. I., 2022, In: Kidney International Reports. 7, 1, p. 36-45Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021
Rossing, Peter & Epstein, M., 2022, In: American Journal of Medicine. 135, 5, p. 576-580 5 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor
Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Ruilope, L. M., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Sarafidis, P., Schmieder, R. E., Joseph, A., Rethemeier, N., Nowack, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Hypertension. 79, 12, p. 2685-2695 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes
Safi, M., Borup, A., Stevns Hansen, C., Rossing, Peter, Thorsten Jensen, M. & Christoffersen, Christina, 2022, In: Diabetes Research and Clinical Practice. 189, 7 p., 109943.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
Schnell, O., Battelino, T., Bergenstal, R., Blüher, M., Böhm, M., Brosius, F., Carr, R. D., Ceriello, A., Forst, T., Giorgino, F., Guerci, B., Heerspink, H. J. L., Itzhak, B., Ji, L., Kosiborod, M., Lalić, N., Lehrke, M., Marx, N., Nauck, M., Rodbard, H. W. & 10 others, , 2022, In: Cardiovascular Diabetology. 21, 1, 50.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, Peter, Wolthers, B., Zinman, B. & Perkovic, V., 2022, In: Circulation. 145, 8, p. 575-585 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial
Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Jensen, Jacob Kildevang, Hansen, T. W. & Rossing, Peter, 2022, In: Diabetes, Obesity and Metabolism. 24, 8, p. 1638-1642Research output: Contribution to journal › Letter › Research › peer-review
ID: 12937790
Most downloads
-
266
downloads
Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
213
downloads
Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
171
downloads
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease
Research output: Contribution to journal › Journal article › Research › peer-review
Published